Cargando…

Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis

BACKGROUND: The Coronavirus disease 2019 (COVID-19) pandemic has extraordinarily impacted global healthcare. Neuro-oncological surgery units have peculiar features that make them highly relevant in the strategic reaction to the pandemic. In this Chinese Society of Neuro-Oncology (CSNO) initiated sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Hameed, N. U. Farrukh, Ma, Yixin, Zhen, Zili, Wu, Shuai, Feng, Rui, Li, Weiping, Huang, Guodong, Wu, Jinsong, Chen, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812331/
https://www.ncbi.nlm.nih.gov/pubmed/33461509
http://dx.doi.org/10.1186/s12893-021-01055-z
_version_ 1783637647808266240
author Hameed, N. U. Farrukh
Ma, Yixin
Zhen, Zili
Wu, Shuai
Feng, Rui
Li, Weiping
Huang, Guodong
Wu, Jinsong
Chen, Zhongping
author_facet Hameed, N. U. Farrukh
Ma, Yixin
Zhen, Zili
Wu, Shuai
Feng, Rui
Li, Weiping
Huang, Guodong
Wu, Jinsong
Chen, Zhongping
author_sort Hameed, N. U. Farrukh
collection PubMed
description BACKGROUND: The Coronavirus disease 2019 (COVID-19) pandemic has extraordinarily impacted global healthcare. Neuro-oncological surgery units have peculiar features that make them highly relevant in the strategic reaction to the pandemic. In this Chinese Society of Neuro-Oncology (CSNO) initiated survey, we appraise the changes implemented in neuro-oncological surgery hospitals across different Asian countries and provide expert recommendations for responses at different stages of the pandemic. METHODS: We performed a 42-question survey of the early experience of neuro-oncological surgery practice in hospitals across different Asian countries on April 1, 2020, with responses closed on April 18, 2020. RESULTS: 144 hospitals completed the questionnaire. Most were in WHO post-peak phase of the pandemic and reported a median reduction in neuro-oncological surgery volume of 25–50%. Most (67.4%) resumed elective surgery in only COVID-19 negative patients;11.1% performed only emergency cases irrespective of COVID-19 status;2.1% suspended all surgical activity. Ninety-one (63.2%) relocated personnel from neurosurgery to other departments. Fifty-two (36.1%) hospitals suspended post-operative adjuvant therapy and 94 (65.2%) instituted different measures to administer post-operative adjuvant therapy. Majority (59.0%) of the hospitals suspended research activity. Most (70%) respondents anticipate that current neurosurgery restrictions will continue to remain for > 1 month. CONCLUSIONS: Majority of the respondents to our survey reported reduced neuro-oncological surgery activity, policy modification, personnel reallocation, and curtailment of educational/research activities in response to the COVID-19 pandemic. The persistent widespread interruption of surgical neuro-oncology in even post-peak phases of the pandemic raises serious concerns about the long-term impact of the pandemic on neuro-oncological patients and highlights the essence of timely measures for pandemic preparedness, patient triage, and workforce protection.
format Online
Article
Text
id pubmed-7812331
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78123312021-01-18 Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis Hameed, N. U. Farrukh Ma, Yixin Zhen, Zili Wu, Shuai Feng, Rui Li, Weiping Huang, Guodong Wu, Jinsong Chen, Zhongping BMC Surg Research Article BACKGROUND: The Coronavirus disease 2019 (COVID-19) pandemic has extraordinarily impacted global healthcare. Neuro-oncological surgery units have peculiar features that make them highly relevant in the strategic reaction to the pandemic. In this Chinese Society of Neuro-Oncology (CSNO) initiated survey, we appraise the changes implemented in neuro-oncological surgery hospitals across different Asian countries and provide expert recommendations for responses at different stages of the pandemic. METHODS: We performed a 42-question survey of the early experience of neuro-oncological surgery practice in hospitals across different Asian countries on April 1, 2020, with responses closed on April 18, 2020. RESULTS: 144 hospitals completed the questionnaire. Most were in WHO post-peak phase of the pandemic and reported a median reduction in neuro-oncological surgery volume of 25–50%. Most (67.4%) resumed elective surgery in only COVID-19 negative patients;11.1% performed only emergency cases irrespective of COVID-19 status;2.1% suspended all surgical activity. Ninety-one (63.2%) relocated personnel from neurosurgery to other departments. Fifty-two (36.1%) hospitals suspended post-operative adjuvant therapy and 94 (65.2%) instituted different measures to administer post-operative adjuvant therapy. Majority (59.0%) of the hospitals suspended research activity. Most (70%) respondents anticipate that current neurosurgery restrictions will continue to remain for > 1 month. CONCLUSIONS: Majority of the respondents to our survey reported reduced neuro-oncological surgery activity, policy modification, personnel reallocation, and curtailment of educational/research activities in response to the COVID-19 pandemic. The persistent widespread interruption of surgical neuro-oncology in even post-peak phases of the pandemic raises serious concerns about the long-term impact of the pandemic on neuro-oncological patients and highlights the essence of timely measures for pandemic preparedness, patient triage, and workforce protection. BioMed Central 2021-01-18 /pmc/articles/PMC7812331/ /pubmed/33461509 http://dx.doi.org/10.1186/s12893-021-01055-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Hameed, N. U. Farrukh
Ma, Yixin
Zhen, Zili
Wu, Shuai
Feng, Rui
Li, Weiping
Huang, Guodong
Wu, Jinsong
Chen, Zhongping
Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis
title Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis
title_full Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis
title_fullStr Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis
title_full_unstemmed Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis
title_short Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis
title_sort impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812331/
https://www.ncbi.nlm.nih.gov/pubmed/33461509
http://dx.doi.org/10.1186/s12893-021-01055-z
work_keys_str_mv AT hameednufarrukh impactofapandemiconsurgicalneurooncologymaintainingfunctionalityintheearlyphaseofcrisis
AT mayixin impactofapandemiconsurgicalneurooncologymaintainingfunctionalityintheearlyphaseofcrisis
AT zhenzili impactofapandemiconsurgicalneurooncologymaintainingfunctionalityintheearlyphaseofcrisis
AT wushuai impactofapandemiconsurgicalneurooncologymaintainingfunctionalityintheearlyphaseofcrisis
AT fengrui impactofapandemiconsurgicalneurooncologymaintainingfunctionalityintheearlyphaseofcrisis
AT liweiping impactofapandemiconsurgicalneurooncologymaintainingfunctionalityintheearlyphaseofcrisis
AT huangguodong impactofapandemiconsurgicalneurooncologymaintainingfunctionalityintheearlyphaseofcrisis
AT wujinsong impactofapandemiconsurgicalneurooncologymaintainingfunctionalityintheearlyphaseofcrisis
AT chenzhongping impactofapandemiconsurgicalneurooncologymaintainingfunctionalityintheearlyphaseofcrisis